Samarth Kulkarni

Microsoft Office 365 Drupal Oracle Cloud Citrix NetScaler ServiceNow Nginx Vimeo Google Analytics Mobile Friendly Typekit New Relic Google Tag Manager Remote AI

gene editing hematology immunooncology biotechnology: biological products (no diagnostic substances) health care biotechnology research crispr bioengineering cell therapy hemoglobinopathies sickle cell disease beta thalassemia immuno-oncology autoimmune diseases in vivo regenerative medicine crispr/cas9 therapeutics patient advocacy clinical trials investigational medicines precision medicine biotechnology genetic diseases patient engagement clinical research gene therapies ex vivo transformative therapies bioethical practices partnerships research collaboration scalable manufacturing genome editing gmp facilities molecular biology therapeutic pipelines fda approval disease modification genetic engineering patient-centered care nobel prize scientific innovation healthcare disparities diversity in biotech community engagement market access health equity community awareness regulatory compliance drug development biopharma investor relations clinical development intellectual property crispr/cas9 technology transformative medicines beta-thalassemia car-t cell therapy cardiovascular diseases genetic disorders personalized treatment pharmaceutical industry patient-centric approach strategic partnerships vertex pharmaceuticals nkarta therapeutics casebia therapeutics innovative therapies rare diseases healthcare professionals genetic counselors biotechnology collaborations market expansion in vivo programs advanced genetic engineering patient outcomes healthcare innovation transformative gene-based therapies health wellness & fitness hospital & health care